With the exception of GPC3 in 15 weeks HIF-1α ASO treated mice, HCC markers were upregulated in HIFα ASO-treated HCC mice compared to scrambled ASO-treated HCC mice, both in the preventive and therapeutic setting (Figure 4C). Here, HIF1A is linked to hepatocellular carcinoma.